Diabetes management software from Tandem gets FDA OK

02/28/2013 | San Diego Business Journal

The FDA has cleared Tandem Diabetes Care to market its t:connect diabetes management software. The technology, set to be released next month, provides diabetes patients and their doctors with electronic access to information from the company's t:slim insulin delivery systems and blood glucose monitors.

View Full Article in:

San Diego Business Journal

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC